Biogen, Ionis spinal muscular atrophy therapy meets study goal

August 1, 2016 11:34 AM

22 0

Biogen, Ionis spinal muscular atrophy therapy meets study goal

Nusinersen demonstrated statistically significant improvement in certain motor functions

Biogen Inc. and Ionis Pharmaceuticals Inc. said their investigational treatment for infantile-onset spinal muscular atrophy demonstrated statistically significant improvement in certain motor functions, according to an interim analysis of late-stage study data.

Also read: FDA OKs 2nd gene therapy for blood cancer; 1st for adults

Read more

To category page

Loading...